About us | BERLIN-CHEMIE

Committed to health

For over 100 years, BERLIN-CHEMIE has stood for innovative research and production of newly developed as well as proven pharmaceutical products. Our goal is to introduce new drugs to help ill patients and improve their quality of life.

As part of the global MENARINI Group, the leading Italian pharmaceutical company, BERLIN-CHEMIE is responsible for the pharmaceutical markets in Germany, Eastern Europe and the CIS region.

NEWS - Latest news

CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

11/13/2020

Menarini Group: committed to fighting today's COVID-19 pandemic with an eye to averting similar health crises in the future

10/27/2020

Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant

7/23/2020

Menarini Group Completes Acquisition of Stemline Therapeutics

6/10/2020

BERLIN-CHEMIE

About us

Learn more about the business fields, the development and the history of BERLIN-CHEMIE.

MENARINI Group
READ MORE

Our Goal
READ MORE

Board of Management
READ MORE

Contact
READ MORE